RediTrex is a Subcutaneous Injection, Solution in the Human Prescription Drug category. It is labeled and distributed by Cumberland Pharmaceuticals Inc.. The primary component is Methotrexate.
Product ID | 66220-825_27143f5b-2401-425a-b0b9-98200d947a35 |
NDC | 66220-825 |
Product Type | Human Prescription Drug |
Proprietary Name | RediTrex |
Generic Name | Methotrexate |
Dosage Form | Injection, Solution |
Route of Administration | SUBCUTANEOUS |
Marketing Start Date | 2020-07-01 |
Marketing Category | NDA / NDA |
Application Number | NDA210737 |
Labeler Name | Cumberland Pharmaceuticals Inc. |
Substance Name | METHOTREXATE |
Active Ingredient Strength | 25 mg/mL |
Pharm Classes | Folate Analog Metabolic Inhibitor [EPC],Folic Acid Metabolism Inhibitors [MoA] |
NDC Exclude Flag | N |
Listing Certified Through | 2021-12-31 |
Marketing Start Date | 2020-07-01 |
NDC Exclude Flag | N |
Sample Package? | N |
NDC | Brand Name | Generic Name |
---|---|---|
66220-815 | RediTrex | RediTrex |
66220-825 | RediTrex | RediTrex |
66220-807 | RediTrex | RediTrex |
66220-810 | RediTrex | RediTrex |
66220-817 | RediTrex | RediTrex |
66220-812 | RediTrex | RediTrex |
66220-820 | RediTrex | RediTrex |
66220-822 | RediTrex | RediTrex |
0143-9367 | Methotrexate | Methotrexate |
0143-9516 | Methotrexate | Methotrexate |
0143-9517 | Methotrexate | Methotrexate |
0143-9518 | Methotrexate | Methotrexate |
0143-9519 | Methotrexate | Methotrexate |
0143-9830 | Methotrexate | Methotrexate |
0378-0014 | Methotrexate | methotrexate |
0555-0572 | Methotrexate | Methotrexate |
0703-3671 | Methotrexate | Methotrexate |
0703-3675 | Methotrexate | Methotrexate |
0703-3678 | Methotrexate | Methotrexate |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
REDITREX 87700133 not registered Live/Pending |
Cumberland Pharmaceuticals Inc. 2017-11-28 |